Phase II study of carboplatin in children with progressive low-grade gliomas

Journal of Clinical Oncology

Volumn 20, Issue 13, 2002, Pages 2951-2958

  Gururangan, Sridharan ^a   Cavazos, Christina M ^a   Ashley, David ^a   Herndon II, James E ^a   Bruggers, Carol S ^a   Moghrabi, Albert ^a   Scarcella, Deborah L ^a   Watral, Melody ^a   Tourt Uhlig, Sandra ^a   Reardon, David ^a   Friedman, Henry S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; IFOSFAMIDE; LOMUSTINE; VINCRISTINE;

ARTICLE; BONE MARROW SUPPRESSION; CANCER GROWTH; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIENCEPHALON; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOMA; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; NEOPLASM STAGING; SALVAGE THERAPY; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036644885     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.12.008     Document Type: Article

References (35)

1. Survival of children with brain tumors: SEER program, 1973-1980
2. Multidisciplinary management of pediatric low-grade gliomas
3. The long-term effects of central nervous system therapy on children with brain tumors
4. Long-term effects of treatment on endocrine function in children with brain tumors
5. Vascular malformation with radiation vasculopathy after treatment of chiasmatic/hypothalamic glioma
6. Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma
7. Cyclophosphamide for the treatment of progressive low-grade astrocytoma: A Pediatric Oncology Group phase II study
8. Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide
9. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An update
10. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood
11. Chemotherapy for low-grade gliomas
12. Chemotherapy: Low-grade gliomas of the hypothalamus and thalamus
13. An integrated approach to the treatment of chiasmatic-hypothalamic gliomas
14. Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma
15. Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A Pediatric Oncology Group randomized phase II study
16. Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy
17. Nonparametric estimation from incomplete observations
18. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples
19. Pediatric phase I trial of carboplatin: A Childrens Cancer Study Group report
20. Carboplatin is effective therapy for young children with progressive optic pathway tumors: A Pediatric Oncology Group phase II study
21. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas
22. Initial management of children with hypothalamic and thalamic tumors and the modifying role of neurofibromatosis-1
23. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up
24. Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma
25. Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study
26. Intracranial gliomas in neurofibromatosis type 1
27. Optic pathway tumors in children: The effect of neurofibromatosis type 1 on clinical manifestations and natural history
28. The management of brainstem gliomas in patients with neurofibromatosis 1
29. Special issues in the management of gliomas in children with neurofibromatosis 1
30. Brainstem tumors in patients with neurofibromatosis type 1: A distinct clinical entity
31. Neurofibromatosis and childhood leukaemia/lymphoma: A population-based UKCCSG study
32. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis
33. Carboplatin hypersensitivity in children: A report of five patients with brain tumors
34. Weekly dosing of carboplatin increases risk of allergy in children
35. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions